MabDesign’s Immunowatch is a one-of-a-kind information monitoring newsletter in the field of biologics. Its aim is to provide members of our association with the most recent and pertinent data gathered or generated through the key expertise of MabDesign and its collaborators in scientific research, business intelligence, market analysis and intellectual property.
Each edition will focus on trending type of biologics. Its general format includes market study research, financial and economic data, invited contributions from scientific teams working in the industry or in academia and a section dedicated to intellectual property. The content of each edition is decided by an editorial composed of two field experts. Decision concerning the theme and conception of each newsletter is done in-house by the permanent members of our editorial team.
Finally, we would like to acknowledge the support of the Ambition Recherche & Développement (ARD) Biomédicaments 2020 Phase II programme, funded by the Centre Val de Loire region during the initial phases of launching this newsletter.
